Cases & Deals

Axis Capital, Religare Capital Markets, and Jefferies India complete INR 4 billion qualified institutions placement and Regulation S offering by SeQuent Scientific Limited

Clients Axis Capital Limited, Religare Capital Markets Limited, and Jefferies India Private Limited

Jones Day represented Axis Capital Limited, Religare Capital Markets Limited, and Jefferies India Private Limited, as placement agents, in connection with the INR 4 billion (US$65 million) of Equity Shares in a qualified institutions placement pursuant to Regulation S of the United States Securities Act of 1933, as amended, by SeQuent Scientific Limited, a developer of animal health and human health related pharmaceutical products which are marketed and sold in India, United States, Europe, Middle East, North Africa, and Latin America.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.